Palatin Technologies Inc. Stock
Our community identified positive and negative aspects for Palatin Technologies Inc. stock for the coming years. 0 users see the criterium "General Risks" as a plus for the Palatin Technologies Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Palatin Technologies Inc. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Palatin Technologies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Palatin Technologies Inc. | - | - | - | - | - | - | - |
| Avita Medical Ltd | -1.990% | 2.730% | -7.385% | -76.111% | -78.029% | -51.840% | -80.949% |
| Immutep LTD ADR | 1.600% | 12.613% | 62.338% | 28.866% | 25.628% | 45.349% | 3.306% |
| India Globalization Capital | 22.220% | -27.737% | -25.000% | -41.420% | -41.071% | -34.044% | -85.751% |
Comments
Palatin Technologies Inc (NYSE: PTN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for PTN provided by MarketBeat
Palatin Technologies Inc (NYSE: PTN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for PTN provided by MarketBeat
Palatin Technologies Inc (NYSE: PTN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for PTN provided by MarketBeat